Bigul

Outcome of Board Meeting

Sub: Outcome of the Board Meeting July 27, 2017 Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2017....
27-07-2017
Bigul

Glenmark Pharma gets USFDA approval for skin cream generic

Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Desonide cream, used to treat a variety of skin conditions. Glenmark Pharmaceuticals...
25-07-2017
Bigul

Earnings Call Slated For Friday, July 28, 2017 At 10:00 A.M. 11:00 A.M.(IST)

Enclosed please find herewith the details of Earnings Call slated for Friday, July 28, 2017 at 10:00 a.m. 11:00 a.m. (IST), for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.
25-07-2017
Bigul

Press Release

Dear Sirs, Sub:- Glenmark Pharmaceuticals receives ANDA approval for Desonide Cream, 0.05% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking you,
25-07-2017
Bigul

Glenmark ties up with Cyndea Pharma to develop soft-gelatin capsules

Drugmaker Glenmark Pharmaceuticals has entered into an agreement with Spain's Cyndea Pharma SL to exclusively use its technology for developing generic, softgelatin capsule formulations for certain...
19-07-2017
Bigul

Press Release

Dear Sirs, Sub:- Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L. for Generic Soft-Gelatin Capsule Drug Products With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.
19-07-2017
Bigul

Shareholding for the Period Ended June 30, 2017

Glenmark Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
17-07-2017
Bigul

Credit Rating

Sub:- Credit Rating by Fitch Ratings Glenmark would like to inform you that, our credit rating has been reaffirmed by Fitch Ratings and remains unchanged, as part of their annual review cycle. In addition, Fitch has reconfirmed 'BB' issue rating on the senior unsecured notes issued last year. They have revised the outlook from 'Positive' to 'Stable', based on their internally defined criteria....
14-07-2017
Bigul

Closure of Trading Window

Sub:- Board Meeting We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Thursday, July 27, 2017 to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2017....
13-07-2017
Bigul

Board Meeting On July 27, 2017

Dear Sirs, Sub:- Board Meeting We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on...
13-07-2017
Next Page
Close

Let's Open Free Demat Account